FDA Inspection 954842 — Centrient Pharmaceuticals India Private Limited
The FDA completed an inspection of Centrient Pharmaceuticals India Private Limited on Dec 18, 2015 in Nawashahr. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 18, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nawashahr (India)